|
23.05.2007 
Peter Löscher (49), currently President of Global Human Health,
Merck & Co. Inc., headquartered in Whitehouse Station, New Jersey (U.S.),
will be the new President and CEO of Siemens AG. The Supervisory Board of
Siemens AG approved the proposal of its Chairman’s Committee to appoint Löscher
a full member of the Managing Board of Siemens AG and Siemens President and CEO
at an extraordinary meeting in Munich on May 20, 2007. Löscher will take office
on July 1, 2007. Dr. Klaus Kleinfeld (49) will step down as Siemens President
and CEO, effective June 30, 2007.
“In Peter Löscher, we have found an exceptional individual for the office of
President and CEO of Siemens AG. His upright character, his global background,
his outstanding international reputation and his wide-ranging experience in
business development and strategy, the financial markets and technology-related
issues were the key factors in our decision. I am convinced that Mr. Löscher
has what it takes to steer Siemens through its current difficulties and into a
better future. I am looking forward to our collaboration with great pleasure,”
said Gerhard Cromme, Chairman of Siemens’ Supervisory Board.
“It is a great honor and an extraordinary challenge to have been appointed
President and CEO of Siemens AG. I know Siemens as one of the world’s foremost
corporate addresses and as a company with a rich tradition and strong
foundations. I am looking forward to assuming the leadership of Siemens and
the overall responsibility for benefiting the company’s customers, employees,
investors and shareholders. My wife, my children and I are all delighted to be
moving back to Europe and to Germany,” said Peter Löscher, the future President
and CEO of Siemens AG.
Born on September 17, 1957 in Villach, Austria, Löscher studied economics
in Vienna, Hong Kong and at Harvard Business School in the United States.
He began his professional career in 1985 at the German management consultants
Kienbaum & Partner. From 1988 to 2002, he held a variety of posts at Hoechst AG
and, following its merger with Rhone Poulenc Rohrer, at Aventis – working in
Germany, the U.S., Spain, the UK and Japan. As head of corporate planning, he
made a major contribution to transforming the company from a highly diversified
conglomerate to a focused life sciences enterprise. He was subsequently appointed
Chairman, President and CEO of Aventis Pharma Ltd. In 2002, he moved to the UK
life sciences company Amersham and, following its acquisition by General Electric,
joined the GE Corporate Executive Council. Since 2006, Peter Löscher has
been a member of the Executive Committee at Merck, one of the world’s leading
pharmaceutical companies, and President of Merck’s Global Human Health division.
|
